Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000950170-24-123443
Filing Date
2024-11-07
Accepted
2024-11-07 16:39:05
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3 s-3_svb_resale.htm S-3 359221
2 EX-5.1 achv-ex5_1.htm EX-5.1 17432
3 EX-23.2 achv-ex23_2.htm EX-23.2 4739
4 EX-FILING FEES achv-exfiling_fees.htm EX-FILING FEES 39230
5 GRAPHIC img223336490_0.jpg GRAPHIC 17749
  Complete submission text file 0000950170-24-123443.txt   446455
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-283070 | Film No.: 241436543
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)